Prediction of Early Neoadjuvant Chemotherapy Response of Breast Cancer through Deep Learning-based Pharmacokinetic Quantification of DCE MRI

By afschroeder • August 28, 2025

Wu C, Wang L, Wang N, Shiao S, Dou T, Hsu YC, Christodoulou AG, Xie Y, Li D. Prediction of Early Neoadjuvant Chemotherapy Response of Breast Cancer through Deep Learning-based Pharmacokinetic Quantification of DCE MRI. Radiol Artif Intell. 2025 Sep;7(5):e240769. doi: 10.1148/ryai.240769. PMID: 40631989.

Tags: biomedical sciences, Breast, Cedars Sinai DoM, Dynamic Contrast-enhanced MRI, Hematology/Oncology, prognosis, Publications, Tumor Response

Related Posts

Impact of Donor Age on Graft Failure After Deceased Donor Liver Transplantation by Donor-Recipient Sex Combinations: An Analysis of the UNOS OPTN Database

Han S, Agopian VA, Steggerda JA, Kim IK, Sanford A, Lee YT, Kwon JH, Rhu JS, Kim GS, Yang JD. Impact of Donor Age on[...]

In the time of COVID-19: challenges, successes, and lessons learned from studies in cancer patients

Mack PC, Crawford JM, Chang A, Yin A, Klein SL, Shea P, Hirsch FR, Zidar D, Simon V, Gleason C, McBride R, Cordon-Cardo C, VanOudenhove[...]

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel

Singal AG, Quirk L, Boike J, Chernyak V, Feng Z, Giamarqo G, Kanwal F, Ioannou GN, Manes S, Marrero JA, Mehta N, Pillai A, Shaheen[...]